血小板：类风湿性关节炎治疗的潜在靶点？ - Suppr | 超能文献

相似文献

1

Platelets: a potential target for rheumatoid arthritis treatment?血小板：类风湿性关节炎治疗的潜在靶点？

Expert Rev Clin Immunol. 2019 Jan;15(1):1-3. doi: 10.1080/1744666X.2019.1544071. Epub 2018 Nov 13.

2

The role of P2Y₁₂ receptor and activated platelets during inflammation.P2Y₁₂受体及活化血小板在炎症过程中的作用。

Curr Drug Targets. 2014;15(7):720-8. doi: 10.2174/1389450115666140519162133.

3

Platelet P-selectin is significantly involved in leukocyte-endothelial cell interaction in murine antigen-induced arthritis.血小板P-选择素在小鼠抗原诱导性关节炎的白细胞-内皮细胞相互作用中起重要作用。

Platelets. 2007 Aug;18(5):365-72. doi: 10.1080/09537100701191315.

4

Ticagrelor added to methotrexate improves rheumatoid arthritis disease severity.替格瑞洛联合甲氨蝶呤可改善类风湿性关节炎的疾病严重程度。

Rheumatology (Oxford). 2021 Nov 3;60(11):5473-5475. doi: 10.1093/rheumatology/keab481.

5

Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer.替格瑞洛抑制人类和鼠类乳腺癌中的血小板-肿瘤细胞相互作用和转移。

Clin Exp Metastasis. 2018 Feb;35(1-2):25-35. doi: 10.1007/s10585-018-9874-1. Epub 2018 Jan 11.

6

Role of newly formed platelets in thrombus formation in rat after clopidogrel treatment: comparison to the reversible binding P2Y₁₂ antagonist ticagrelor.氯吡格雷治疗后大鼠血栓形成中新形成的血小板的作用：与可逆结合的 P2Y₁₂拮抗剂替卡格雷的比较。

Thromb Haemost. 2011 Dec;106(6):1179-88. doi: 10.1160/TH11-04-0252. Epub 2011 Nov 10.

7

Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis.抗瓜氨酸化蛋白抗体在类风湿关节炎中促进血小板活化。

Arthritis Res Ther. 2015 Aug 24;17(1):209. doi: 10.1186/s13075-015-0665-7.

8

Cangrelor in Ticagrelor-Loaded STEMI Patients Undergoing Primary Percutaneous Coronary Intervention.替格瑞洛负荷剂量治疗的ST段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗时使用坎格雷洛的情况

J Am Coll Cardiol. 2018 Oct 2;72(14):1750-1751. doi: 10.1016/j.jacc.2018.07.041.

9

Ticagrelor: A promising role in preventing multi-organ failure among patients with sepsis due to resistant gram-positive cocci.替格瑞洛：在预防耐甲氧西林革兰氏阳性球菌所致脓毒症患者多器官功能衰竭方面具有潜在作用。

J Microbiol Immunol Infect. 2019 Aug;52(4):513-515. doi: 10.1016/j.jmii.2019.06.004. Epub 2019 Jun 26.

10

Platelet Reactivity And Circulating Platelet-Derived Microvesicles Are Differently Affected By P2Y Receptor Antagonists.血小板反应性和循环血小板衍生微泡受到 P2Y 受体拮抗剂的不同影响。

Int J Med Sci. 2019 Jan 1;16(2):264-275. doi: 10.7150/ijms.28580. eCollection 2019.

引用本文的文献

1

Platelet-Derived Soluble CD40L and Its Impact on Immune Modulation and Anti-IL6R Antibody Treatment Outcome in Rheumatoid Arthritis.血小板衍生的可溶性CD40L及其对类风湿关节炎免疫调节和抗IL6R抗体治疗结果的影响

Cells. 2025 Apr 22;14(9):625. doi: 10.3390/cells14090625.

2

Application Value of Platelet-to-Lymphocyte Ratio as a Novel Indicator in Rheumatoid Arthritis: A Review Based on Clinical Evidence.血小板与淋巴细胞比值作为类风湿关节炎新型指标的应用价值：基于临床证据的综述

J Inflamm Res. 2024 Oct 23;17:7607-7617. doi: 10.2147/JIR.S477262. eCollection 2024.

3

Identification of key genes and long non‑coding RNA expression profiles in osteoporosis with rheumatoid arthritis based on bioinformatics analysis.